Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report: November 3, 2011

(Date of earliest event reported)

 

 

TENET HEALTHCARE CORPORATION

(Exact name of Registrant as specified in its charter)

 

 

 

Nevada   1-7293   95-2557091
(State of Incorporation)  

(Commission

File Number)

 

(IRS Employer

Identification Number)

1445 Ross Avenue, Suite 1400

Dallas, Texas 75202

(Address of principal executive offices, including zip code)

(469) 893-2200

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

(a) The 2011 annual meeting of shareholders of Tenet Healthcare Corporation was held on November 3, 2011.

(b) The shareholders (1) elected all of the board’s nominees for director, (2) approved an advisory resolution on the compensation paid to the company’s named executive officers, (3) indicated their preference that future advisory votes on executive compensation be held annually, and (4) ratified the selection of Deloitte & Touche LLP as the company’s independent registered public accountants for the year ending December 31, 2011.

The final results of voting on each of the matters submitted to a vote are as follows:

1. Election of directors:

 

     FOR      AGAINST      ABSTAIN      BROKER
NON-VOTES
 

John Ellis “Jeb” Bush

     272,644,691         101,937,787         1,143,911         47,148,731   

Trevor Fetter

     318,677,997         56,976,353         72,039         47,148,731   

Brenda J. Gaines

     302,048,388         72,534,943         1,143,058         47,148,731   

Karen M. Garrison

     273,023,919         101,552,463         1,150,007         47,148,731   

Edward A. Kangas

     277,761,550         97,787,981         176,858         47,148,731   

J. Robert Kerrey

     272,775,886         101,766,006         1,184,497         47,148,731   

Floyd D. Loop, M.D.

     272,569,686         101,996,230         1,160,473         47,148,731   

Richard R. Pettingill

     316,341,476         58,222,458         1,162,455         47,148,731   

Ronald A. Rittenmeyer

     316,716,390         57,852,958         1,157,041         47,148,731   

James A. Unruh

     272,402,123         102,180,537         1,143,729         47,148,731   

2. Approval of an advisory resolution on the compensation paid to the company’s named executive officers:

 

FOR

 

AGAINST

 

ABSTAIN

 

BROKER NON-VOTES

320,317,032   53,062,153   2,347,204   47,148,731

 

2


3. Approval, on an advisory basis, of the option of every “1 Year,” “2 Years,” or “3 Years” for future advisory votes on executive compensation:

 

1 YEAR

 

2 YEARS

 

3 YEARS

 

ABSTAIN

 

BROKER NON-
VOTES

327,108,888   748,570   44,212,107   3,656,824   47,148,731

4. Ratification of the selection of Deloitte & Touche LLP as the company’s independent registered public accountants for the year ending December 31, 2011:

 

FOR

 

AGAINST

 

ABSTAIN

 

BROKER NON-
VOTES

421,406,996   1,294,912   173,212  

(d) Based on the results of the advisory vote on the frequency of future advisory votes on executive compensation, and consistent with the recommendation of the board, the board adopted a resolution providing that an advisory vote on the compensation of the company’s named executive officers would be held annually until the next advisory vote on the frequency of future advisory votes on executive compensation.

 

3


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

TENET HEALTHCARE CORPORATION
By:   /s/ Gary Ruff
 

Gary Ruff

Senior Vice President and General Counsel

Date: November 4, 2011

 

4